NKTR - Nektar Therapeutics - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - NKTR (906709)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
39 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-02-20
NKTRZalevsky JonathanChief R, D OfficerS - Sale$0.68-9,014265,025-3%-$6,130
2024-02-20
NKTRWilson Mark AndrewGCS - Sale$0.68-7,606236,674-3%-$5,172
2024-02-20
NKTRRobin Howard WPres, CEOS - Sale$0.68-20,033880,299-2%-$13,622
2023-11-17
NKTRZalevsky JonathanChief R, D OfficerS - Sale$0.49-9,646274,039-3%-$4,727
2023-11-17
NKTRWilson Mark AndrewGCS - Sale$0.49-7,179243,780-3%-$3,518
2023-11-17
NKTRRobin Howard WPres, CEOS - Sale$0.49-19,877900,332-2%-$9,740
D
2023-09-18
NKTRCuret MyriamDirS - Sale+OE$0.69-4,35927,418-14%-$3,008
D
2022-09-22
NKTRChess RobertDirS - Sale+OE$0.67-10,200281,073-4%-$6,834
D
2023-09-18
NKTRAjer Jeffrey RobertDirS - Sale+OE$0.69-4,35934,153-11%-$3,008
2023-08-16
NKTRZalevsky JonathanChief R, D OfficerS - Sale$0.78-9,703283,685-3%-$7,568
2023-08-16
NKTRWilson Mark AndrewGCS - Sale$0.78-7,221250,959-3%-$5,632
2023-08-16
NKTRRobin Howard WPres, CEOS - Sale$0.78-19,998920,209-2%-$15,598
2023-06-14
NKTRWhitfield Roy ADirS - Sale$0.57-30,000287,750-9%-$17,100
2023-05-16
NKTRZalevsky JonathanChief R, D OfficerS - Sale$0.72-9,791293,388-3%-$7,050
2023-05-16
NKTRWilson Mark AndrewGCS - Sale$0.72-7,543257,680-3%-$5,431
2023-05-16
NKTRRobin Howard WPres, CEOS - Sale$0.72-20,361940,207-2%-$14,660
2023-02-16
NKTRZalevsky JonathanChief R, D OfficerS - Sale$3.00-10,484303,179-3%-$31,452
2023-02-16
NKTRWilson Mark AndrewGCS - Sale$3.00-8,275265,223-3%-$24,825
2023-02-16
NKTRThomsen Jillian B.CFOS - Sale$3.00-10,267313,497-3%-$30,801
2023-02-16
NKTRRobin Howard WPres, CEOS - Sale$3.00-19,635960,568-2%-$58,905
2022-11-16
NKTRZalevsky JonathanChief R, D OfficerS - Sale$3.57-13,460313,663-4%-$48,052
2022-11-16
NKTRWilson Mark AndrewGCS - Sale$3.57-8,690272,498-3%-$31,023
2022-11-16
NKTRThomsen Jillian B.CFOS - Sale$3.57-11,095323,764-3%-$39,609
2022-11-16
NKTRRobin Howard WPres, CEOS - Sale$3.57-38,014980,203-4%-$135,710
2022-09-23
NKTRCuret MyriamDirS - Sale$3.16-4,19831,777-12%-$13,266
2022-09-23
NKTRAjer Jeffrey RobertDirS - Sale$3.16-4,19838,512-10%-$13,266
2022-09-22
NKTRChess RobertDirS - Sale$3.19-5,100291,273-2%-$16,269
2022-09-13
NKTREastham KarinDirS - Sale$3.61-21,26713,033-62%-$76,774
2022-08-18
NKTRZalevsky JonathanChief R, D OfficerS - Sale$4.65-73,716327,123-18%-$342,779
D
2022-08-16
NKTRZalevsky JonathanChief R, D OfficerS - Sale+OE$4.76-10,560400,839-3%-$50,266
D
2022-08-16
NKTRWilson Mark AndrewSVP, GCS - Sale+OE$4.76-3,189281,188-1%-$15,180
D
2022-08-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$4.76-2,006334,859-1%-$9,549
D
2022-08-16
NKTRRobin Howard WPres, CEOS - Sale+OE$4.76-13,7591,018,217-1%-$65,493
2022-05-16
NKTRZalevsky JonathanChief R, D OfficerS - Sale$3.95-21,673276,399-7%-$85,608
2022-05-16
NKTRWilson Mark AndrewSVP, GCS - Sale$3.95-3,136117,939-3%-$12,387
2022-05-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$3.95-5,841170,427-3%-$23,072
2022-05-16
NKTRRobin Howard WPres, CEOS - Sale$3.95-36,529621,351-6%-$144,290
2022-05-16
NKTRNorthcott JohnSVP, Chief Commercial OfficerS - Sale$3.95-4,592223,210-2%-$18,138
2022-05-16
NKTRLabrucherie Gil MSVP, COO, CFOS - Sale$3.95-17,448312,905-5%-$68,920

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top